Robin Spiller
Robin Spiller
University of Nottingham, Nottingham Digestive Diseases Centre
Verified email at nottingham.ac.uk
Title
Cited by
Cited by
Year
Functional bowel disorders
GF Longstreth, WG Thompson, WD Chey, LA Houghton, F Mearin, ...
Gastroenterology 130 (5), 1480-1491, 2006
62572006
Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acuteCampylobacter enteritis and in post-dysenteric irritable bowel syndrome
RC Spiller, D Jenkins, JP Thornley, JM Hebden, T Wright, M Skinner, ...
Gut 47 (6), 804-811, 2000
13282000
Bowel disorders
BE Lacy, F Mearin, L Chang, WD Chey, AJ Lembo, M Simren, R Spiller
Gastroenterology 150 (6), 1393-1407. e5, 2016
10982016
Guidelines on the irritable bowel syndrome: mechanisms and practical management
R Spiller, Q Aziz, F Creed, A Emmanuel, L Houghton, P Hungin, R Jones, ...
Gut 56 (12), 1770-1798, 2007
10092007
Rome III The functional gastrointestinal disorders
A Drossman
Gastroenterology 130, 1377-1556, 2006
9582006
Intestinal microbiota in functional bowel disorders: a Rome foundation report
M Simrén, G Barbara, HJ Flint, BMR Spiegel, RC Spiller, S Vanner, ...
Gut 62 (1), 159-176, 2013
8872013
Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients
KR Neal, J Hebden, R Spiller
Bmj 314 (7083), 779, 1997
8241997
Postinfectious irritable bowel syndrome
R Spiller, K Garsed
Gastroenterology 136 (6), 1979-1988, 2009
7782009
Bowel disorders.
F Mearin, BE Lacy, L Chang, WD Chey, AJ Lembo, M Simren, R Spiller
Gastroenterology, 2016
7232016
Eradication of Helicobacter pylori using one‐week triple therapies combining omeprazole with two antimicrobials: the MACH I Study
T Lind, SV van Zanten, P Unge, R Spiller, E Bayerdörffer, C O'Morain, ...
Helicobacter 1 (3), 138-144, 1996
7071996
Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS
SP Dunlop, D Jenkins, KR Neal, RC Spiller
Gastroenterology 125 (6), 1651-1659, 2003
6612003
The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies
T Lind, F Mégraud, P Unge, E Bayerdörffer, C O'Morain, R Spiller, ...
Gastroenterology 116 (2), 248-253, 1999
5451999
The ileal brake--inhibition of jejunal motility after ileal fat perfusion in man.
RC Spiller, IF Trotman, BE Higgins, MA Ghatei, GK Grimble, YC Lee, ...
Gut 25 (4), 365-374, 1984
5031984
Effect of meal viscosity and nutrients on satiety, intragastric dilution, and emptying assessed by MRI
L Marciani, PA Gowland, RC Spiller, P Manoj, RJ Moore, P Young, ...
American Journal of Physiology-Gastrointestinal and Liver Physiology 280 (6 …, 2001
4932001
Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes
SP Dunlop, J Hebden, E Campbell, J Naesdal, L Olbe, AC Perkins, ...
American Journal of Gastroenterology 101 (6), 1288-1294, 2006
4922006
Postinfectious irritable bowel syndrome
RC Spiller
Gastroenterology 124 (6), 1662-1671, 2003
4902003
Intestinal barrier function in health and gastrointestinal disease
M Camilleri, K Madsen, R Spiller, BG Van Meerveld, GN Verne
Neurogastroenterology & Motility 24 (6), 503-512, 2012
4752012
Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome
SP Dunlop, D Jenkins, RC Spiller
The American journal of gastroenterology 98 (7), 1578-1583, 2003
4232003
Irritable bowel syndrome: a little understood organic bowel disease?
NJ Talley, R Spiller
The Lancet 360 (9332), 555-564, 2002
3982002
Mechanisms of hypersensitivity in IBS and functional disorders
F Azpiroz, M Bouin, M Camilleri, EA Mayer, P Poitras, J Serra, RC Spiller
Neurogastroenterology & Motility 19, 62-88, 2007
3712007
The system can't perform the operation now. Try again later.
Articles 1–20